Tris-benzimidazole derivatives: design, synthesis and DNA sequence recognition

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Organic Synthesis

Background:

• Bis-benzimidazole compounds like Hoechst 33258 are known DNA stains.
• Structural modifications of bis-benzimidazoles can alter DNA binding properties.
• Understanding structure-activity relationships is key for developing novel DNA-binding agents.

Purpose of the Study:

• To design and synthesize novel tris-benzimidazole derivatives.
• To investigate the effect of substituents on DNA binding affinity and sequence selectivity.
• To compare the DNA binding characteristics of new tris-benzimidazoles with existing bis-benzimidazoles.

Main Methods:

• Chemical synthesis of two tris-benzimidazole derivatives with modified substituents.
• DNA binding studies using footprinting experiments.
• Nuclear Magnetic Resonance (NMR) and X-ray crystallography data informed the design.

Main Results:

• The synthesized tris-benzimidazoles exhibit strong AT-base pair selectivity.
• The derivative with a 2-amino-pyrrolidine ring showed enhanced DNA binding compared to the N-methyl-piperazine derivative.
• Footprinting experiments revealed protection of 5-6 base pairs by tris-benzimidazoles, exceeding bis-benzimidazoles (4-5 base pairs).
• Selective binding to AT-rich sequences was confirmed, with weak binding to sequences containing a single GC pair.

Conclusions:

• Tris-benzimidazole derivatives with specific substituents demonstrate improved DNA binding and AT-sequence selectivity.
• These novel compounds represent potential advancements over existing bis-benzimidazole DNA stains.
• The findings provide insights into the rational design of DNA-interacting small molecules.